Matinas BioPharma
MTNB
MTNB
48 hedge funds and large institutions have $15.1M invested in Matinas BioPharma in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $18M → $15.1M (-$2.9M)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$529K | |
| 2 | +$297K | |
| 3 | +$249K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$88.7K |
| 5 |
Morgan Stanley
New York
|
+$77.3K |
Top Sellers
| 1 | -$159K | |
| 2 | -$86K | |
| 3 | -$80.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$61K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$47.8K |